A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial

2020

Journal Article

Author(s)

Janssen, M.

Schäkel, U.

Djuka Fokou, C.

Krisam, J.

Stermann, J.

Kriegsmann, K.

Haberbosch, I.

Novotny, J.P.

Weber, S.

Vehreschild, M.

Bornhäuser, M.

Bullinger, L.

Schmitt, M.

Liebregts, T.

Dreger, P.

Lorenz, H.-M.

Plaszczyca, A.

Bartenschlager, R.

Müller, B.

Kräusslich, H.-G.

Halama, N.

Jäger, D.

Schlenk, R.F.

Leo, A.

Meuer, S.

Weigand, M.A.

Motsch, J.

Merle, U.

Denkinger, C.M.

Müller-Tidow, C.

Journal